Navigation Links
U of M faculty find antimicrobials altering intestinal bacteria composition in swine
Date:9/4/2012

MINNEAPOLIS/ST. PAUL (09/04/2012) Researchers from the University of Minnesota's College of Veterinary Medicine, concerned about the use of antibiotics in animal production, have found that antimicrobial growth promoters administered to swine can alter the kind of bacteria present in the animal's intestinal track, resulting in an accelerated rate of growth and development in the animals.

Antibiotics are routinely administered to swine to treat illness and to promote larger, leaner animals.

The results of the study, conducted by Richard Isaacson, Ph.D., microbiologist and professor within the University of Minnesota's College of Veterinary Medicine, alongside his U of M and University of Illinois research teams, were published yesterday in the journal PNAS.

To arrive at their results, the researchers tracked the effects of the antimicrobial Tylosin. The effects were observed in the feces of commercial pigs on two farms in southwestern Minnesota.

In young pigs receiving Tylosin, the intestinal bacterial composition changed and was similar to the composition naturally accredited to an older animal. These changes are linked to improved growth and stimulate an early maturation of the immune system.

"Bacterial composition drives the ability of animals to grow and thrive by contributing to digestion and metabolism," said Isaacson. "Because the bacteria in more mature animals break down growth-promoting components in food more efficiently, younger animals are able to achieve adult size and an adult-like metabolic rate more quickly."

According to Isaacson, the question has now shifted to whether or not researchers can use this new understanding to recreate this ideal-growth composition in swine produced for human consumption without antibiotic use.


'/>"/>

Contact: Miranda Taylor
tayl0551@umn.edu
612-626-2767
University of Minnesota Academic Health Center
Source:Eurekalert

Page: 1

Related biology news :

1. 2 UNC faculty receive Autism Centers of Excellence grants for new research
2. IU biologist receives Department of Energys top young faculty award
3. Antimicrobials from personal care products found in statewide survey of Minnesotas rivers and lakes
4. Natural regeneration building urban forests, altering species composition
5. Plastic trash altering ocean habitats, Scripps study shows
6. Intestinal bacteria produce neurotransmitter, could play role in inflammation
7. Johns Hopkins researchers uncover genes at fault for cystic fibrosis-related intestinal obstruction
8. Danger in the blood: U-M scientists show how antibiotic-resisting bacterial infections may form
9. New bacteria-resistant materials discovered
10. Frequent traveller: Dysentery-causing bacteria spreading from Europe to Australia
11. Bacterial community inside the plant root
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Nov. 18, 2016 Securus Technologies, a leading ... public safety, investigation, corrections and monitoring, announced today that ... ICSolutions, to have an independent technology judge determine who ... modern high tech/sophisticated telephone calling platform, and the best ... they do most of what we do – which ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. ... company focused on developing and commercializing products to treat ... announced today that it will be hosting an Investor ... ET on the origins of innate defense regulators (IDRs) ... review of oral mucositis and the recently announced and ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selectorâ„¢ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest Inc. ... and commercialization of immunotherapeutic products for the treatment ... into an Antibody Manufacturing Development Program with Cytovance ... USA) for its oregovomab antibody product. Supported by ... IIb clinical study in ovarian cancer patients, OncoQuest ...
(Date:12/7/2016)... , Dec. 7, 2016  Vyriad Inc. announced today ... the company,s Board of Directors. "We are ... build our business and develop our oncolytic viruses as ... said Stephen Russell , MD, PhD, CEO of ... share our vision and passion for making a difference ...
Breaking Biology Technology: